Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
24.07.25
/
50%
€20.00
Target price
24.07.26
€28.88
Performance (%)
1.75%
Price
20.02.26
€20.35
Summary
This prediction is currently active. With a performance of 1.75%, the BUY prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals is trending in the right direction. This prediction currently runs until 24.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 9.409% | 9.409% |
| iShares Core DAX® | 0,61 % | 0,34 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % |
| iShares S&P 500 | 0,54 % | -0,70 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.43
17.11.25
17.11.25
€26.71
17.11.26
17.11.26
1.96%
20.02.26
20.02.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
12.00%
20.02.26
20.02.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
5.55%
20.02.26
20.02.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25